Ortho Regenerative Technologies today said it appointed Mukesh Ahuja as VP of clinical and medical affairs, effective Nov. 1.
Prior to joining the company, Ahuja worked at Orthofix Medical where he was responsible for developing the clinical strategy for the motion preservation program of the spine business franchise. He has also served as the director of medical and clinical affairs at Medacta.
“It is with great pleasure that we welcome Dr. Ahuja to the Ortho RTI team. With the start of its rotator cuff tear repair clinical program insight, Ortho RTI has reached a development stage that requires highly specialized expertise and years of experience in managing complex clinical orthopedics research programs. Mukesh brings all of that and more with him,” president and CEO Claude LeDuc said in a news release. “Ortho will also greatly benefit from Mukesh’s track record in supporting the development and commercialization of medical products and technologies as we continue building our Ortho-R product’s portfolio of indications in various new musculoskeletal conditions such as tendonitis, ligament and meniscus tears and cartilage lesions as well as a new formulation for OA.”
“I am very excited to be joining Ortho RTI at such a crucial time in its clinical development. There are clear unmet medical needs in the space of soft tissue repair and regenerative medicine that can be addressed with Ortho RTI’s technological platform. I look forward to contributing to the advancement of Ortho RTI’s clinical program and working with the team in positioning the company as a leader in the orthopedic and sports related injury surgeries,” Ahuja said.